Dr. Fabrice Laroche, an accomplished life scientist, has an extensive background in molecular biology, genetics, and nanotechnology for cancer research. He received his Ph.D. in Molecular Biology from Aarhus Universitet and his Diplome de l`EPHE in Genetics from Ecole pratique des Hautes Etudes. Dr. Laroche was a Research Fellow at Leiden University and a Prodoctoral Fellow at Aarhus University, where he gained visibility in developmental biology and biochemistry.

His professional career then took him to the Boston University School of Medicine-Pharmacology and Experimental Therapeutics, where he worked as a Postdoctoral Associate and a Research Scientist between 2013 and 2017. During his tenure at Boston University, Dr. Laroche received a grant and training in nanotechnology for cancer from XTNC-BUnano Innovation Center, which further sharpened his expertise in cancer research.

Currently, Dr. Laroche is the Owner and Founder of Laroche, a company based in Oregon, USA. His company is focused on developing nanotechnology solutions for cancer, leveraging his expertise in the field.

Dr. Laroche's professional experience and expertise lie in molecular biology, genetics, nanotechnology for cancer research, and developmental biology. He has worked in several institutions in different countries and has earned various accolades throughout his career, including a nanotechnology for cancer grant and training from XTNC-BUnano Innovation Center.